Résultat(s) 1 - 5 résultats de 5 pour la requête 'Seyed Reza Mousavi (13223324)', Temps de recherche: 0,01s Affiner les résultats
  1. 1
    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.

    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites. par Seyed Reza Mousavi (13223324)

    Publié 2025
    Ajouter aux favoris
    Enregistré dans:
  2. 2
    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].

    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58]. par Seyed Reza Mousavi (13223324)

    Publié 2025
    Ajouter aux favoris
    Enregistré dans:
  3. 3
    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.

    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites. par Seyed Reza Mousavi (13223324)

    Publié 2025
    Ajouter aux favoris
    Enregistré dans:
  4. 4
    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites. par Seyed Reza Mousavi (13223324)

    Publié 2025
    Ajouter aux favoris
    Enregistré dans:
  5. 5
    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites. par Seyed Reza Mousavi (13223324)

    Publié 2025
    Ajouter aux favoris
    Enregistré dans:

Outils de recherche: